3-KAT: A Potential Drug Target for Energy Metabolism (P41842)

Target Name: 3-Ketoacyl-CoA Thiolase (3-KAT)

NCBI ID: P41842

3-Ketoacyl-CoA Thiolase (3-KAT)

Other Name(s): 3-Ketoacyl-CoA Thiolase | 3-KAT

3-KAT: A Potential Drug Target for Energy Metabolism

3-Ketoacyl-CoA Thiolase (3-KAT) is an enzyme that plays a crucial role in the metabolism of fatty acids and ketones. It is a key enzyme in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA ) cycle, which is responsible for generating energy in the form of ATP from the food we eat.

3-KAT is a protein that is expressed in most tissues of the body and is involved in the citric acid cycle. It is a subunit of the TCA cycle and is localized to the mitochondria. 3-KAT catalyzes the conversion of 3-ketoacyl- CoA (3-KAC) to 2-ketoglutarate (2-KET) via a series of intermediate steps.

The 3-KAT enzyme has been identified as a potential drug target in the field of metabolism and diseases. Its role in the TCA cycle makes it a promising target for interventions that target energy metabolism and the associated diseases, such as obesity, diabetes, and fatty liver diseases.

3-KAT has been shown to be involved in the regulation of energy metabolism and has been linked to the development and progression of several diseases. For example, 3-KAT has been shown to be involved in the development of obesity and non-alcoholic fatty liver disease (NAFLD).

In addition to its potential as a drug target, 3-KAT has also been shown to be a valuable biomarker for monitoring the progression of certain diseases. For example, the levels of 3-KAT have been shown to be elevated in the blood of obese individuals compared to those who are normal weight.

3-KAT has also been shown to be involved in the regulation of cellular signaling pathways. For example, 3-KAT has been shown to be involved in the regulation of the unfolded protein response (UPR), a signaling pathway that is involved in the regulation of protein structure and function.

In conclusion, 3-Ketoacyl-CoA Thiolase (3-KAT) is a protein that plays a crucial role in the metabolism of fatty acids and ketones. Its role in the TCA cycle makes it a promising target for interventions that target energy metabolism and the associated diseases. Its potential as a drug target and biomarker make it an attractive target for future research.

Protein Name: 3-Ketoacyl-CoA Thiolase (3-KAT) (nonspecified Subtype)

The "3-Ketoacyl-CoA Thiolase (3-KAT) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about 3-Ketoacyl-CoA Thiolase (3-KAT) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets